Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUCMSCs and hCBMNCs with HRT in Premature Ovarian Failure
NCT01742533Phase 2Unknown
- Sponsor
- Beike Biotechnology
- Start
- Mar 2012
- Primary completion
- Jun 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells, umbilical cord blood mononuclear cells in primary ovarian insufficiency (POI), sponsored by Beike Biotechnology. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cellsumbilical cord blood mononuclear cells
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT01742533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01742533.